Test DescriptionHuman FLT3 Mutation Detection Kit is used to qualitatively detectthe mutation status of FLT3 gene in genomic DNA extracted fromhuman blood samples or bone marrow samples, and can be usedfor prognostic stratification of acute myeloid l

The transmembrane receptor-like protein encoded by the proto-oncogene Human Epidermal Growth Factor Receptor 2 (HER2) gene has tyrosine kinase activity, and HER2 is an important prognostic factor for breast cancer. Breast cancer with HER2 gene amplif

This kit uses PCR+CE methods to detect nine mononucleotide repeat sites including BAT25, BAT26, NR21, NR24, MONO27, BAT52, BAT56, BAT59, and BAT60 in tumor tissues to guide the diagnosis of colorectal cancer patients, especially treated with immune c

The c-MET exon 14 skipping mutation exists in a variety of solid tumors, mainly in non-small cell lung cancer (NSCLC). The mutation rate in lung adenocarcinoma is about 3%, and the mutation rate in lung squamous cell carcinoma is about 2%, especially

Myeloproliferative-Neoplasms（MPN）is a group of clonal hematopoietic stem cell diseases characterized by the continuous proliferation of one or more myeloid lineages in the bone marrow. The WHO 2016 classification of MPN includes seven sub-types, am

The BCR-ABL fusion gene detection kit is a quantitative BCR-ABL1 p210 assay using quantitative PCR (qPCR）.